Imunon, Inc.
Income Statement
| Line Item | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $125.0K | $125.0K | $125.0K | $125.0K | $125.0K | $125.0K | $125.0K | $125.0K |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | $3.0M | $2.4M | $3.2M | $3.1M | $3.0M | $2.5M | $2.6M | $2.6M |
| SG&A Expense | $4.0M | $3.9M | $2.9M | $2.9M | $2.6M | $2.7M | $2.6M | $2.9M |
| Operating Income | $-6.9M | $-6.2M | $-6.0M | $-5.8M | $-5.5M | $-5.1M | $-5.1M | $-5.4M |
| Operating Margin | -5,541.4% | -4,939.7% | -4,782.6% | -4,673.6% | -4,392.7% | -4,049.3% | -4,057.1% | -4,306.7% |
| Interest Expense | — | $127.0K | $105.0K | — | — | $95.5K | $221.2K | — |
| Pretax Income | — | — | — | — | — | — | — | — |
| Income Tax Expense | — | — | — | — | — | — | — | — |
| Net Income | $-13.2M | $-6.1M | $-6.0M | $-10.5M | $-4.2M | $-5.4M | $-5.4M | $-5.7M |
| Net Margin | -10,586.1% | -4,918.6% | -4,834.3% | -8,379.5% | -3,377.0% | -4,328.4% | -4,358.7% | -4,551.2% |
| EPS (Basic) | $-1.47 | $-0.87 | $-0.87 | $-1.82 | $1.37 | $-0.94 | $-0.95 | $-3.31 |
| EPS (Diluted) | — | $-0.87 | $-0.87 | — | $-3.62 | $-0.06 | $-0.06 | $-0.09 |
| Shares Outstanding (Basic) | 7.1M | 7.1M | 7.0M | 5.8M | 5.4M | 5.8M | 5.7M | 1.7M |
| Shares Outstanding (Diluted) | 7.1M | 7.1M | 7.0M | 5.8M | 5.4M | 5.8M | 5.7M | 1.7M |
| Dividends Per Share | — | — | — | — | — | — | — | — |